n-3 Polyunsaturated fatty acids and cytokine production in health and disease

Annals of Nutrition and Metabolism

Volumn 41, Issue 4, 1997, Pages 203-234

  Colder, Philip C ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cytokine; Eicosanoid; Fish oil; Interleukin; Lymphocyte; Macrophage; Polyunsaturated fatty acid

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; CYTOKINE; DOCOSAHEXAENOIC ACID; FISH OIL; ICOSANOID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; POLYUNSATURATED FATTY ACID; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANIMAL EXPERIMENT; AUTOIMMUNITY; CELL TYPE; CHRONIC INFLAMMATION; DIET SUPPLEMENTATION; FAT INTAKE; FEMALE; GUINEA PIG; HUMAN; HUMAN EXPERIMENT; INFLAMMATORY DISEASE; LYMPHOCYTE; MACROPHAGE; MALE; MONKEY; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT; REVIEW; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SWINE;

EID: 0030846940     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000177997     Document Type: Article

References (127)

1. Goodwin JS. Cucppens J: Regulation of the immune response by prostaglandins. Clin Immunol 1983:3:295-315.
2. Hwang D: Essential fatty acids and the immune response. FASEB J 1989:3:2052-2061.
3. Kunkel SL. Remick DG. Spengler M. Chensuc SW: Modulation of macrophage-derived interleukin-1 and tumor necrosis factor by prostaglandin Ei. Adv Prostaglandin Thromboxane Leukot Res 1982:9: 331-339.
4. Renz H, Gong JH, Schmidt A, Nain M, Gemsa D: Release of tumor necrosis factor alpha from macrophages: Enhancement and suppression are dose-dcpcndently regulated by prostaglandin Ej and cyclic nucleotides. J Immunol 1988:141: 2388-2393.
5. Endres S, Fülle HJ, Sinha B, Stoll D, Dinarcilo CA, Gcrzcr R, Weber PC: Cyclic nucleotides differentially regulated the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. Immunology 1991;72:56-60.
6. Kovacs EJ, Radzioch D, Young HA, Varesio L: Differential inhibition of IL-1 and TNFu mRN’A expression by agents which block second messenger pathways in murine macrophages. J Immunol 1988:141:3101-3105.
7. Spinas GA, Bloesch D, Keller, Zimmerli W, Cammisuli S: Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha. interleukin-6 and clastase during acute endotoxaemia. J Infect Dis 1991:163:89-95.
8. Schade UF, Ernst M, Reinke M, Wolter DT: Lipoxygenase inhibitors suppress formation of tumor necrosis factor in vitro and in vivo. Bio-cliem Biophys Res Gommun 1989; 159:748-754.
9. Dubois C. Bissonncttc E. Rola-Pleszczynski M: Platelet-activating factor (PAF) stimulates tumor necrosis factor production by alveolar macrophages: Prevention of PAF receptor antagonists and lipoxygenase inhibitors. J Immunol 1989:143: 964-971.
10. Knudsen PJ, Dinarello C, Strom TB: Prostaglandins post-transcrip-tionally inhibit monocyte expression of interleukin-1 activity by increasing cyclic adenosine monophosphate. J Immunol 1986:137: 3187-3194.
11. Scales WE, Chensuc SW, Otterness I, Kunkel SL: Regulation of monokine gene expression: Prostaglandin E; suppresses tumor necrosis factor but not interleukin-1 alpha or beta mRNA and cell-associated b:oactiv-ity. J Leuk Biol 1989:45:416-421.
12. Rola-Pleszczynski M. Lemaire I: Leukotrienes augment interleukin I production by human monocytes. J Immunol 1985:135:3958-3961.
13. Hoffman T, Lee YL. Lizzio EF. Tri-pathi AK, Jessop JJ, Taplitis M, Abrahamscn TG. Carter CS. Puri J: Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxvgenase metabolites: MK-886. indomethacinor ara-chidonate fail to alter immunoreac-tive interleukin-1 beta or TNF-al-pha production by human monocytes in vitro. Clin Immunol Immu-nopathol 1991:58:399-408.
14. Parkar BA, McCormick ME, Foster SJ: Leukotrienes do not regulate in-tcrleukin-1 production by activated macrophages. Biochcm Biophys Res Commun 1990:169:422-429.
15. Poubelle P. Stankova J. Grassii J. Rola-Pleszczynski M: Lcukotriene IL up-regulatcs IL-6 rather than IL-1 synthesis in human monocytes. Agents Actions 1991:34:42-45.
16. Rappaport RS. Dodge GR: Prostaglandin E inhibits production of interleukin-2. J Exp Med 1981:155: 943-948.
17. Walker C. Kristensen F. Bettens F. DeWeck AL: Lymphokine regulation of activated (Gl) lymphocytes. I. Prostaglandin Ey-induced inhibition of interleukin-2 production. J Immunol 1983:130:1770-1773.
18. Chouaib S, Welte K, Mertelsmann R, Dupont B: Prostaglandin Ey acts at two distinct pathways of T-lym-phoevte activation: Inhibition of interleukin^ production and down-regulation oftransferrin receptor expression. J Immunol 1985:135: 1172-1179.
19. Paliogianni F. Kincaid RL. Boum-pas DT: Prostaglandin E and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcincurin-depcn-dent pathways. J Exp Med 1993: 178:1813-1817.
20. Rola-Plcszczvnski M, Gagnon L, Si-rois P: Leukotriene Bj augments human natural cytotoxic cell activity. Biochem Biophys Res Commun 1983:113:531-537.
21. Magrum LJ. Johnston PV: Modulation of prostaglandin synthesis in rat peritoneal macrophages with co-3 fatty acids. Lipids 1983:18:514-521.
22. Lee TH, Hoover RL, Williams JD, Sperling RL, Ravalesc J, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF: Effects of dietary enrichment with EPA and DHA on in vitro neutrophil and monocyte leu-kotrienc generation and neutrophil function. N Engl J Med 1985:312: 1217-1224.
23. Endres S, Ghorbani R. Kelley VE. Gcorgilis K. Lonnemann G. van der Meer JM W. Cannon JG. Rogers TS. Klempner MS. Weber PC. Schaeffer EJ, Wolff SM. Dinarello CA: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989:320: 265-271.
24. Lokesh BR. Hsich HL. Kinsella JE: Peritoneal macrophages from mice fed dietary (n-3) polyunsaturated fatty acids secrete low levels of prostaglandins. J Nutr 1986:116:2547-2552.
25. Hardardotlir I. Kinsella JE: Tumour necrosis factor production by murine resident peritoneal macrophages is enhanced by dietary n-3 polyunsaturated fatty acids. Bio-chim Biophys Acta 1991:1095:187-195.
26. Hardardotlir I, Kinsella JE: Increasing the dietary (n-3) to (n-6) polyunsaturated fatty acid ratio increases tumor necrosis factor production by murine resident peritoneal macrophages without an effect on elicited peritoneal macrophages. JNutr 1992;122:1942-1951.
27. Brouard C. Pascaud M: Effects of moderate dietary supplementations with n-3 fatty acids on macrophage and lymphocyte phospholipids and macrophage eicosanoid synthesis in the rat. Biochim Biophys Acta 1990: 1047:19-28.
28. Fritsche KL, Alexander DW, Cassi-ty NA, Huang S-C: Maternally supplied fish oil alters piglet immune cell fatty acid profile and eicosanoid production. Lipids 1993:28:677-682.
29. Black JM. Kinsella JE: Dietary n-3 fatty acids alter mouse peritoneal macrophage cytotoxicity. Ann Nutr Metab 1993:37:110-120.
30. Yaqoob P. C'alder PC: Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 1995:163:120-128.
31. Grimm ingcr F. Führer D. Papavas-silis C. Schlotzer E, Mayer K, Heuer K-U. Kiss L. Walmrath D. Piberhof-er S. Lubbecke F, Kramer H-J, Stevens J. Schutterle G. Seeger W: influence of intravenous n-3 lipid supplementation on fatty acid profiles and lipid mediator generation in a patient with severe ulcerative colitis. Eur J Clin Invest 1993:23:706-715.
32. Billiar T. Bankey P. Svingcn B. Curran RD. West MA. Holman RT. Simmons RL. Cerra FB: Fatty acid uptake and Kupffer cell function: Fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery 1988:104:343-349.
33. Chact MS, Garcia VF, Arya G, Ziegler MM: Dietary fish oil enhances macrophage production of nitric oxide. J SurgRcs 1994:57:65-68.
34. Turck JJ. Schoenlein LA. Clark LK. van Alstine WG: Dietary polyunsaturated fatty acids effects on immune cells of the porcine lung. J Leuk Biol 1994;56:599-604.
35. Grimm H. Tibell A. Norrlind B. Blecher C. Wilker S, Schwemmle K: lmmunoregulation by parenteral lipids: Impact of the n-3 to n-6 fatty acid ratio. J Parenter Enter Nutr 1994;18:417-421.
36. Lokcsh BR. Sayers TJ. Kinsella JE: Interleukin-1 and tumor necrosis factor synthesis by mouse peritoneal macrophages is enhanced by dietary n-3 polyunsaturated fatty acids. Immunol Lett 1990:23:281-286.
37. Watanabe S. Hayashi H. Onozaki K. Okuvama H: Effect of dietary a-linolcnate/linoleatc balance on lipo-polysaccharide-induced tumor necrosis factor production in mouse macrophages. Life Sci 1991;48: 2013-2020.
38. Blok WL, Vogels MT, Curfs JH, El-ing WM, Buurman WA, van der Meer JWM: Dietary fish oil supplementation in experimental gramnegative infection and in cerebral malaria in mice. J Infect Dis 1992: 165:898-903.
39. Turek JJ. Schoenlein IA. Bottoms GD: The effect of dietary n-3 and n-6 fatty acids on tumor necrosis factor-a production and leucine aminopeptidasc levels in rat peritoneal macrophages. Prostaglandins Leukot Essent Fatty Acids 1991:43: 141-149.
40. Boutard V, Fouqucry B, Philippe C, Perez J, Baud L: Fish oil supplementation and essential fatty acid deficiency reduce nitric oxide synthesis by rat macrophages. Kidr.cy Int 1994:46:1280-1286.
41. Chang HR. Arscnijcvic D. Pechere JC. Piguct PF. Mcnsi N. Girardier L. Dulloo AG: Dietary supplementation with fish oil enhances in vivo synthesis of tumor necrosis factor. Immunol Lett 1992:34:13-18.
42. Renicr G. Skamene E. de Sanctis J. Radzioch D: Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice: Modulation of macrophage secretory activities. Artcrio-scler Thomb 1993:13:1515-1524.
43. Somers SD. Erickson KL: Alteration of tumor necrosis factor-u production by macrophages from mice fed diets high in cicosapcntaenoic and docosahexaenoic acids. Cell Immunol 1994:153:287-297.
44. Hubbard NE. Chapkin RS. Erickson KL: Effect of dietary linseed oil on lumoricidal activity and eicosanoid production in murine macrophages. Lipids 1994;29:651-655.
45. Wallace FA, Neeley SJ, Miles EA, Calder PC: Dietary fish oil decreases the production of pro-inflammatory mediators by murine macrophages. Proc Nutr Soc. in press.
46. Tappia PS. Grintble RF: Complex modulation of cytokine induction by endotoxin and tumour necrosis factor from peritoneal macrophages of rats by diets containng fats of different saturated, monounsaturated and polyunsaturated fatty acid composition. Clin Sci 1994:87:173-178.
47. Ertel W, Morrison MIL, Ayala A, Chaudry IH: Modulation of macrophage membrane phospholipids by n-3 polyunsaturated fatty acids increases interleukin I release and prevents suppression of cellular immunity following hemorrhagic shock. Arch Surg 1993:128:15-21.
48. Tappia PS, Man WJ. Grimble RF: influence of unsalurated fatty acids on the production of tumour necrosis factor and interleukin-6 by rat peritoneal macrophages. Mol Cell Biochem 1995;143:89-98.
49. Chandrasekar B, Fernandes G: Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by to-3 lipids in murine lupus nephritis. Biochem Biophys Res Commun 1994:200:893-898.
50. Hubbard NE. Somers SD. Erickson KL: Eicosapcntaenoic and doxosa-hexaenoic acids alter macrophage TNFa activity. Cytokine 1991:3: 462.
51. Fernandes G. Bysani C. Venkatraman JT. Tomar V. Zhao W: Increased TGF-p and decreased oncogene expression by co-3 fatty acids in the spleen delays onset of autoimmune disease in B/W mice. J Immunol 1994;152:5979-5987.
52. Yaqoob P. Caldcr PC: The effects of dietary lipid manipulation on the production of murine T-cell-derivcd cytokines. Cvtokine 1995:7:548-553.
53. Wu D. Meydani SN. Meydani M. Hayek MG. Huth P. Nicolosi RJ: Immunologic effects of marine-and plant-derived n-3 polyunsaturated fatty acids in nonhuman primates. Am J Clin Nulr 1996:63:273-280.
54. Jolly CA. Jiang Y-H. Chapkin RS. McMurray DN: Dietary (n-3) polyunsaturated fatty acids suppress murine lymphoprolifération, interleukin-2 secretion, and the formation of diacylglycérol and ceramide. J Nutr 1997:127:37-43.
55. Calder PC. Newsholmc EA: Unsaturated fatty acids suppress interleukin-2 production and transferrin receptor expression by concanavalin A-stimulated rat lymphocytes. Medial Inllamm 1992:1:107-115.
56. Krcmer JM. Lawrence DA. Jubiz W. Di Giacomo R, Rynes K. Bartholomew LE, Sherman M: Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Arthritis Rheum 1990:33: 810-820.
57. Meydani SN. Endres S. Woods MM. Goldin BR. Soo C, Morrill-Labrode A. Dinarello C, Gorbach SL: Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. J Nutr 1991:121:547-555.
58. Virella G, Fourspring K, Hyman B, Haskill-Stroud R, Long L, Virella I, La Via M, Gross AJ, Lopes-Virella M: Immunosuppressive effects of fish oil in normal human volunteers: Correlation with the in vitro effects of cicosapentaenoic acid on human lymphocytes. Clin Immunol Immu-nopathol 1991;61:161-176.
59. Molvig J. Pociot F. Worsaae H. Wo-gensen LD. Back L. Christensen P. Mandrup-Poulscn T. Andersen K. Madsen P. Dyerberg J, Ncrup J: Dietary supplementation with co-3 polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-115 content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand J Immunol 1991; 34:399-410.
60. Cooper AL, Gibbons L, Horan MA, Little RA, Rothwell NJ: Effect of dietary fish oil supplementation on fever and cytokine production in human volunteers. Clin Nutr 1993:12: 321-328.
61. Meydani SN. Lichtenstein AH. Cornwall S. Meydani M. Goldin BR, Rasmussen H, Dinarello CA. Schaefer FJ: Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty acid enrichment. J Clin Invest 1993:92:105-113.
62. Gallai V. Sarchielli P. Trcquattrini A. Franccschini M. Floridi A, Fi-rcnce C, Alberti A, Dibenedetto D, Stragliotto E: Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neurointmunol 1993;56:143-153.
63. Soyland E, Lea T, Sandstad B, Dre-von A: Dietary supplementation with very long chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases. Eur J Clin Invest 1994;24:236-242.
64. Endres S. Meydani SN. Ghorbani R. Schindler R. Dinarello CA: Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leuk Biol 1993:54:599-603.
65. Caughey GE, Mantzioris E, Gibson RA, Clcland LG, James MJ: The effect on human tumor necrosis factor a and interleukin I p production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996:63:116-122.
66. Calder PC, Ncwsholme EA: Polyunsaturated fatty acids suppress human peripheral blood lymphocyte proliferation and interleukin-2 production. Clin Sci 1992:82:695-700.
67. Wan JM, Grimblc RF: Effect of dietary linoleatc content on the metabolic response of rats to Escherichia coli endotoxin. Clin Sci 1987:72: 383-385.
68. Bibby DC, Grimble RF: Dietary fat modifies some metabolic actions of human recombinant tumour necrosis factor a in rats. Br J Nutr 1990: 63:653-668.
69. Mascioli EA, Leader L, Flores E. Trimbo S, Bistrian B. Blackburn G: Enhanced survival to endotoxin in guinea pigs fed iv fish oil emulsion. Lipids 1988:23:623-625.
70. Mascioli EA. Iwasa Y, Trimbo S. Leader L, Bistrian BR, Blackburn GL: Endotoxin challenge after menhaden oil diet: Effects on survival of guinea pigs. Am J Clin Nutr 1989; 49:277-282.
71. Pomposelli JJ. Flores E. Hirschberg Y. Teo TC. Blackburn GL. Zeisel SH. Bistrian BR: Short-term TPN containing n-3 fatty acids ameliorates lactic acidosis induced by endotoxin in guinea pigs. Am J Clin Nutr 1990;52:548-552.
72. Pomposelli J, Mascioli EA, Bistrian BR, Flores SM: Attenuation of the febrile response in guinea pigs by fish oil enriched diets. J Parenter Enter Nutr 1990:13:136-140.
73. Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA: Interleukin-1-induced anorexia in the rat: Influence of prostaglandins. J Clin Invest 1989:84:228-235.
74. Hirschberg Y, Pomposelli JJ, Blackburn GL. Istfan NW. Babayan V. Bistrian BR: The effects of chronic fish oil feeding in rats on protein catabolism induced by recombinant mediators. Metabolism 1990:39: 397-402.
75. Teo TC, Sclleck KM, Wan JMF, Pomposelli JJ, Babayan VK, Blackburn GL, Bistrian BR: Long-term feeding with structured lipid composed of medium chain and n-3 fatty acids ameliorates cndotoxic shock in guinea pigs. Metabolism 1991:40: 1152-1159.
76. Watanabc S. Okuyama H: Effect of dietary a-linolenatc/linoleate balance on endotoxin-induced hepatitis in mice. Lipids 1991:26:467-471.
77. Mulrooney HM, Griniblc RF: Influence of butter and of com, coconut and fish oils on the effects of recombinant human tumour necrosis factor-a in rats. Clin Sci 1993:84: 105-112.
78. Chang HR, Dulloo AG, Vladoianu IR, Piguct PF, Arsen ijevic D, Girar-dier L, Pecherc JC: Fish oil decreases natural resistance of mice to infection with Salmonella typhimu-rltim. Metabolism 1992;41:1-2.
79. 4and prostaglandin E? synthesis and the time course of experimental tuberculosis in guinea pigs. Infection 1994;22:106-112.
80. D'Ambola JB, Aeberhard EE, Trang N, Gaffar S, Barrett CT, Sherman MP: Effect of dietary (n-3) and (n-6) fatty acids on in vivo pulmonary bacterial clearance by neonatal rabbits. J Nutr 1991:121:1262-1269.
81. Fritsche KL., Shahbazian LM, Feng C, Berg JN: Dietary fish oil reduces survival and impairs bacterial clearance in C3H/Hen mice challenged with Listeria monocytogenes. Clin Sci 1997;92:95-101.
82. Rubin RH, Wilkinson RA, Xu L, Robinson DR: Dietary marine lipid docs not alter susceptibility of (NZB x NZW) F1 mice to pathogenic microorganisms. Prostaglandins 1989; 38:251-262.
83. Clouva-Molyvdas P. Peck MD. Alexander JW: Short-term dietary lipid manipulation does not affect survival in two models of murine sepsis. J Parenter Enter Nutr 1992:16: 343-347.
84. Fernandes G, Tomar V, Venkatra-man MN, Vcnkatraman JT: Potential of diet therapy in murine AIDS. J Nutr 1992;122:716-722.
85. Prickctt JD. Robinson DR. Steinberg AD: Effects of dietary enrichment with eicosapcntaenoic acid upon autoimmune nephritis in female NZB x NZW/F1 mice. Arthritis Rheum 1983:26:133-139.
86. Robinson DR. Prickctt JD. Polisson R. Steinberg AD. Levine L: The protective effect of dietary fish oil on murine lupus. Prostaglandins 1985; 30:51-75.
87. Robinson DR. Prickctt JD. Makoul GT. Steinberg AD. Colvin RB: Dietary fish oil reduces progression of established renal disease in (NZB x NZW) F1 mice and delays renal disease in BXSB and MRL/t strains. Arthritis Rheum 1986:29:539-546.
88. Robinson DR, Xu L, Tateno S, Guo M, Colvin RB: Suppression of autoimmune disease by dietary n-3 fatty acids. J Lipid Res 1993:34: 1435-1444.
89. Kelley VE, Ferretti A, Izui S. Strom TB: A fish oil diet rich in eicosapen-tacnoic acid reduces cyclooxygenase metabolites and suppresses lupus in MRL-lpr mice. J Immunol 1985: 134:1914-1919.
90. Robinson DR, Knocll CT, Urakaze M. Huang R. Taki H. Sugiyama E, Xu L-L, Yeh ETH. Olesiak'w. Guo M. Colvin RB. Auron PE: Suppression of autoimmune disease by to-3 fatty acids. Biochem Soc Trans 1995;23:287-291.
91. Leslie CA, Conte JM, Hayes KC. Cathcart ES: A fish oil diet reduces the severity of collagen induced arthritis after onset of disease. Clin Exp Immunol 1988;73:328-332.
92. Cathcart ES, Gonnerman WA: Fish oil fatty acids and experimental arthritis. Rheum Dis Clin North Am 1991:17:235-242.
93. Wallace JL, Keenan CM, Finn NJ: Anti-inflammatory effects of a fish oil diet in a rat model of chronic colitis. Gastroenterology 1589:96: A535.
94. Vilaseca J, Salas A, Guamer F, Rodriguez R. Martinez M. Malagelada J-R: Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 1990:31:539-544.
95. Empcy LR. Jewell LD. Garg ML, Thomson AB. Clandinin MT, Fedo-rak RN: Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. Can J Physiol Pharmacol 1991:69:480-487.
96. Guamer F, Vilaseca J, Malagelada JR: Dietary manipulation in experimental inflammatory bowel disease. Agents Actions 1992:spe-cial nuntbenC 10-14.
97. Dyerberg J. Bang HO. Hjornc N: Fatty acid composition of the plasma lipis in Greenland Eskimos. Am J Clin Nutr 1975:28:958-966.
98. Kromann N. Green A: Epidemiological studies in the Upemavik District. Greenland. Acta Med Scand 1980:208:401-406.
99. Kromhout D. Bosschieter EB. de Lezcnne Coulander C: The inverse relationship between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985:312:1205-1208.
100. Krcmcr JM, Bigauoette J, Michal-ek AV, Timchalk MA, Lininger L, Ryncs RI, Huyck C, Zieminski J, Bartholomew LE: Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1985:i: 184-187.
101. Kremer JM, Jubiz W, Michalek A, Ryncs R, Bartholomew LE, Bi-gaouette J, Timchalk M, Beeler D, Lininger L: Fish oil fatty acid supplementation in active rheumatoid arthritis. Ann Intern Med 1987; 106:497-502.
102. Sperling Rl, Weinblatt ME, Robin JL, Ravalese J, Hoover RL, House F, Coblyn JS, Fraser PA, Spur BW, Robinson DR, Lewis RA, Austen KF: Effects of dietary' supplementation with marine fish oil on leukocyte lipid mediator generation and function in rheumatoid arthritis. Arthritis Rheum 1987:30:987-988.
103. Cleland LG, French JK, Betts WH, Murphy GA, Elliott MJ: Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis. J Rheumatol 1988:15: 1471-1475.
104. van der Tcmpcl H, Tulleken JE, Limburg PC, Muskiet FAJ, van Rijswijk MK: Effects of fish oil supplementation in rheumatoid arthritis. Ann Rheum Dis 1990;49: 76-80.
105. Esperson GT, Grunnet N. Lcrvang HU. Nielsen GL. Thomsen BS. Faarvang KL. Dyerberg J, Emst E: Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids. Clin Rheumatol 1992;11:393-395.
106. Kremer JM: Studies on the effects of omega-3 fatty acids in the treatment of patients with rheumatoid arthritis: in Drevon CA. Baksaas I. Krokan HE (eds): Omega-3 Fatty Acids: Metabolism and Biological Effects. Basel. Birkhäuscr. 1993. pp 271-283.
107. Allen BR, Maurice PDL, Good-field MW, Cockbill S, Stammers J: The effect on psoriasis of dietary supplementation with eicosapen-taenoic acid. Br J Dermatol 1985: 113:777.
108. Ziboh VA, Cohen KA, Ellis CN, Miller C, Hamilton TA, Kragballc K, Hydrick CR, Voorhees JJ: Effects of dietary supplementation of fish oil on neutrophil and epidermal fatty acids: Modulation of clinical course of psoriatic lesions. Arch Dermatol 1986; 122:1277-1282.
109. Maurice PDL. Allen BR. Barkley AST, Cockbill SR, Stammers J, Bather PC: The effects of dietary supplementation with fish oil in patients with psoriasis. Br J Dermatol 1987;117:599-606.
110. Bittiner SB, Tucker WFG, Cartwright I, Blechen SS: A doubleblind, randomised, placebo-controlled trial offish oil in psoriasis. Lancet 1988:i:378-380.
111. Bjomcboc A. Smith AK. Bjornc-boe G-EA, Thune PO, Drevon CA: Effect of dietary supplementation with n-3 fatty acids on clinical manifestations of psoriasis. Br J Dermatol 1988:118:77-83.
112. Terano T. Kojima T. Seva A, Ta-nabe E. Hirai A. Makuda H. Ozawa A, Fujita T, Tamura Y, Oka-moto S, Yoshida S: The effect of highly purified eicosapentaenoic acid in patients with psoriasis. Adv Prostaglandin Thromboxane Leu-kotRes 1989:19:610-613.
113. Soyland E. Funk J. Rajka G. Sandberg M. Thune P. Rustad L. Heiland S, Middelfart K, Odu S. Falk ES, Solvoll K. Bjomcboc G-E. Drevon CA: Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis. N Engl J Med 1993:328: 1812-1816.
114. Soyland E. Drevon CA: The effect of very long-chain n-3 fatty acids on immune-related skin diseases. Eur J Clin Nutr 1993:47:381-388.
115. Grimminger F. Mayser P: Lipid mediators, free fatty acids and psoriasis. Prostaglandins Leukot Es-sent Fatty Acids 1995:52:1-15.
116. Swank RL: Multiple sclerosis: A correlation of its incidence with dietary fat. Am J Med Sei 1950:220: 421-430.
117. Mertin J. Meade CJ: Relevance of fatty acids to multiple sclerosis. Br Med Bull 1977;33:67-71.
118. Bates D. Cartlidge NEF, French JM, Jackson MJ. Nightingale S. Shaw DA. Smith S. Woo E. Hawkins SA, Millar JHD. Bclin J. Conroy DM. Gill SK, Sidcy M. Smith AD. Thompson RHS. Zilkha K, Gale M. Sinclair HM: A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989:52:18-22.
119. Schwartz J. Weiss ST: Dietary factors and their relationship to respiratory symptoms: The Second National Health and Nutrition survey. Am J Epidemiol 1990:132: 67-76.
120. Hodge L, Salome CM. Peat JK. Haby MM, Xuan W, Woolcock AJ: Consumption of oily fish and childhood asthma risk. Med J Aust 1996:164:137-140.
121. Hodge L. Peat JK. Salome C: Increased consumption of polyunsaturated oils may be a cause of increased prevalence of childhood asthma. Aust NZJ Med 1994:24: 727.
122. Black PN. Sharp S: Dietary fat and asthma: Is there a connection? Eur RespirJ 1997:10:6-12.
123. Arm J. Horton CE. Menica-Hucrta JM. House F, Eiser NM, Clark TSH. Spur BW. Lee TH: Effect of dietary supplementation with fish oil lipids in mild asthma. Thorax 1988;43:84-92.
124. Picado C. Castillo JA. Schinca N. Pujades M. Ordinas A, Coronas A, Augusti-Vidal A: Effects of fish oil enriched diet on aspirin-tolerant asthmatic patients: A pilot study. Thorax 1988;43:93-97.
125. Clark WF, Parbtani A, HulTMW, Reid B, Holub BJ, Falardeau P: Omcga-3 fatty acid dietary supplementation in systemic lupus erythematosus. Kidney Int 1989:36: 653-660.
126. Wcstberg G. Tarkowski A: Effect of MaxEPA in patients with SLE: Scand J Rheumatol 1990:19:137-143.
127. Das UN: Beneficial effect of cico-sapentaenoic and docosahexaeno-ic acids in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot Es-senl Fatty Acids 1994:51:207-213.